Ospedale Santa Maria Della Misericordia, Perugia, Italy.
J Clin Hypertens (Greenwich). 2013 May;15(5):328-32. doi: 10.1111/jch.12074. Epub 2013 Feb 12.
Studies on the relationship between blood pressure (BP) and mortality among hemodialysis patients have yielded conflicting results. Reports have come mostly from North America and have dealt with dialysis patients as a homogenous population and differed in methods and time of BP measurement and the optimal BP target. In a prospective nationwide study in 3674 unselected Caucasian patients with end-stage renal disease undergoing chronic hemodialysis from 73 dialysis units, the authors sought to examine the relationship between the different measurements of BP and mortality according to antihypertensive treatment. The mean age of patients was 67.2±14.1 years and the prevalence of diabetes was 19.5%. During follow-up (26.5±10.5 months), 977 deaths were recorded. In the whole cohort, BP was not associated with mortality. After grouping the patients according to antihypertensive treatment, the analysis showed that only in patients who did not take antihypertensive medications (1613) was there an inverse relationship between postdialysis systolic BP and mortality. These patients differed from the others in BP, dialysis vintage, prevalence of diabetes, and type of dialysis technique. This study suggests that with respect to the relationship of BP with mortality, dialysis patients are not a homogenous population. Differences in demographic characteristics and in dialysis technique may therefore explain the reported variability of previous results.
关于血液透析患者血压(BP)与死亡率之间关系的研究结果存在矛盾。这些报告主要来自北美,将透析患者视为同质人群,其血压测量方法、时间和最佳血压目标存在差异。在一项针对 73 个透析单位的 3674 名未选择的白种人终末期肾病接受慢性血液透析患者的前瞻性全国性研究中,作者试图根据降压治疗情况,研究不同血压测量值与死亡率之间的关系。患者的平均年龄为 67.2±14.1 岁,糖尿病患病率为 19.5%。在随访期间(26.5±10.5 个月),记录到 977 例死亡。在整个队列中,血压与死亡率无关。根据降压治疗对患者进行分组后,分析表明,只有未服用降压药物的患者(1613 名)透析后收缩压与死亡率呈负相关。这些患者在血压、透析年限、糖尿病患病率和透析技术类型方面与其他患者存在差异。这项研究表明,就血压与死亡率的关系而言,透析患者并非同质人群。因此,人口统计学特征和透析技术的差异可能解释了先前结果的可变性。